Clinical Trial Update: Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease

View source ↗

Summary

This clinical trial update describes a study evaluating ustekinumab for perianal fistulizing Crohn's disease that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: Crohn Disease | Status: NOT_YET_RECRUITING